Evidence map›Paper›PMID 19176890›Full record

ArticleAmerican journal of physiology. Regulatory, integrative and comparative physiology2009

Glycemic control prevents microvascular remodeling and increased tone in type 2 diabetes: link to endothelin-1.

Kamakshi Sachidanandam, Jim R Hutchinson, Mostafa M Elgebaly, Erin M Mezzetti, Anne M Dorrance, Kouros Motamed, Adviye Ergul

Open access · greenAbstract read
In one paragraph

Article in American journal of physiology. Regulatory, integrative and comparative physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Endothelium-dependent impairments to cerebral vascular reactivity with type 2 diabetes mellitus in the Goto-Kakizaki rat.American journal of physiology. Regulatory, integrative and comparative physiology · 2019
    Article
  5. Review
  6. Abnormal myosin phosphatase targeting subunit 1 phosphorylation and actin polymerization contribute to impaired myogenic regulation of cerebral arterial diameter in the type 2 diabetic Goto-Kakizaki rat.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2017
    Article
  7. Linagliptin treatment improves cerebrovascular function and remodeling and restores reduced cerebral perfusion in Type 2 diabetes.American journal of physiology. Regulatory, integrative and comparative physiology · 2016
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Renal autoregulation in health and disease.Physiological reviews · 2015
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Middle cerebral artery alterations in a rat chronic hypoperfusion model.Journal of applied physiology (Bethesda, Md. : 1985) · 2012
    Article
  19. Role of shear stress and stretch in vascular mechanobiology.Journal of the Royal Society, Interface · 2011
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Kamakshi SachidanandamMedical College of Georgia, Augusta, GA 30912, USA.
Jim R Hutchinson
Mostafa M Elgebaly
Erin M Mezzetti
Anne M Dorrance
Kouros Motamed
Adviye Ergul
Augusta University · USAbraxis (United States) · USInstitute of Pharmacology · CZ

Funding

Vascular Protection &Endothelin B Receptors in DiabetesR01DK074385 · NIDDK · UNIVERSITY OF GEORGIA (UGA) · PI ERGUL, ADVIYE · 2005 to 2009
$1.1M
Mechanism of Endothelial Dysfunction in DiabetesR15HL076236 · NHLBI · UNIVERSITY OF GEORGIA (UGA) · PI ERGUL, ADVIYE · 2004 to 2004
$188k
NHLBI NIH HHS R15 HL076236NIDDK NIH HHS DK074385NIDDK NIH HHS R01 DK074385
6 · The paper itself

Abstract

Medial thickening and vascular hypertrophy of resistance arteries can lead to cardiovascular complications associated with diabetes. While previous studies have established a role of type 1 diabetes in vascular remodeling, we recently extended these observations to type 2 diabetes and reported increased collagen deposition due to alterations in matrix metalloproteinase expression and activity in mesenteric resistance arteries. These studies also showed that remodeling response was mediated by endothelin-1 (ET-1) via activation of ET(A) receptors, whereas blockade of ET(B) receptors exacerbated the remodeling. However, the effectiveness of glycemic control strategies in preventing these vascular changes, including activation of the ET system still remained unclear. Also, very little is known about whether and to what extent reorganization of the extracellular matrix (ECM) affects vascular compliance and vasomotor tone. Accordingly, this study assessed structural remodeling of mesenteric microvessels, vascular compliance, and myogenic tone, as well as the role of matrix metalloproteinases (MMP) in mediating these processes. Spontaneously diabetic, non-obese Goto-Kakizaki (GK) rats, a model for type 2 diabetes, and normoglycemic Wistar rats were used for the studies. A subset of GK rats were administered metformin to achieve euglycemia. Glycemic control normalized the increased media-to-lumen ratios (M/L) and myogenic tone seen in diabetes, as well as normalizing plasma ET-1 levels and mesenteric ET(A) receptor expression. There was increased collagen synthesis in diabetes paralleled by decreased collagenase MMP-13 activity, while glycemic control attenuated the process. These findings and our previous study taken together suggest that hyperglycemia-mediated activation of ET-1 and ET(A) receptors alter vascular structure and mechanics in type 2 diabetes.

Indexed as

AnimalsBlood GlucoseCollagenDiabetes Mellitus, Type 2Disease Models, AnimalEndothelin-1HyperplasiaHypoglycemic AgentsMaleMatrix Metalloproteinase 13Mesenteric ArteriesMetforminMicrovesselsRatsRats, WistarReceptor, Endothelin ABlood GlucoseCollagenEndothelin-1Hypoglycemic AgentsMatrix Metalloproteinase 13MetforminMmp13 protein, ratReceptor, Endothelin AReceptor, Endothelin B

Identifiers

PMID19176890
PMCPMC2698601
OpenAlexW2164625528

What OpenQuestion holds

Texttitle and abstract
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.